Abstract
Uniform and Monodisperse AgNPs were synthesized via a simple chemical reduction approach the synthesized AgNPs' characterizations were as follows: UV–Vis analysis displayed Surface plasmon resonance (SPR) of AgNPs peaked around 425 nm. AgNPs were shown to have a crystalline structure with a face-centered cubic (FCC) lattice using X-ray diffraction (XRD) investigation. Transmission electron microscopy (TEM) images illustrated a spherical in shape and well dispersant AgNPs, having a 12 nm average size. The AgNPs' stability was confirmed by dynamic light scattering (DLS) data with the coincidence of hydrodynamic diameter to the nominal particle size obtained from TEM. Interestingly, the synthesized AgNPs demonstrated a dose-dependent reduction of thyroid carcinoma growth, the Papillary (MDA-T22) and the Follicular (FTC-133) cells with determined IC50 values of 71.35 and 52.79 μg/ml, respectively. Meanwhile, against normal cells (WRL-68) the AgNPs had no cytotoxic effect at low concentrations and minimal cytotoxicity at higher of 200–400 μg/ml with a significantly increased IC50 value reached to 218.4 μg ml−1. The induced apoptosis of AgNPs treated cancer cells was determined by a High-content screening (HCS) assay. Moreover, the apoptotic morphological changes were explored and the mechanism of affected living cells to apoptosis showed an increase in cell membrane permeability, cytochrome c level, and nuclear intensity in dose-dependent with a significant deferent at higher concentrations (100 and 200 μg mL−1) (p < 0.0001). Conversely, a noticeable decrease in cell viable count and mitochondrial membrane permeability was observed with AgNPs treatment compared with control. Our findings indicate the potential suitability of these nanoparticles for biological and clinical applications.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.